Verbatim response from ChatGPT
Short answer: Most U.S. guidelines call a morning total testosterone consistently below about 300 ng/dL (≈10.4 nmol/L) as low enough to consider treatment — but treatment is recommended only if you also have symptoms of testosterone deficiency.
What clinicians use in practice
- Important principle: both low lab values and compatible symptoms are required. Common symptoms: low libido, erectile dysfunction, low energy/motivation, depressed mood, reduced muscle mass/strength, increased body fat, and low bone density/fractures.
- Cutoff most often used: total testosterone <300 ng/dL on at least two separate morning (before 10 a.m.) tests on different days. This is the threshold used by the Endocrine Society and American Urological Association.
- If total testosterone is borderline (roughly 200–350 ng/dL) but symptoms are present, clinicians often measure/calculate free or bioavailable testosterone (or check SHBG) because total T can be misleading in obesity, diabetes, liver disease, and with changes in SHBG.
- Very low values (e.g., <200 ng/dL) are more clearly abnormal and warrant evaluation and usually treatment if symptomatic.
How testing and diagnosis are done
- Test as a fasting blood draw in the early morning (ideally before 10 a.m.). Repeat on a separate day to confirm.
- If low: check LH and FSH to distinguish primary (high LH/FSH) from secondary (low/normal LH/FSH) hypogonadism. If secondary, check prolactin and consider pituitary imaging if indicated.
- Also get baseline PSA and hematocrit before starting therapy (and consider lipids and bone density as clinically indicated).
When treatment is appropriate
- Symptomatic men with consistently low morning total T (usually <300 ng/dL) may be offered testosterone therapy after discussing risks/benefits.
- Men who want to preserve fertility should avoid standard exogenous testosterone (it suppresses sperm production). Alternatives to discuss with a specialist: clomiphene citrate or hCG therapy to raise endogenous T without suppressing spermatogenesis.
Risks, contraindications, and monitoring
- Important contraindications/precautions: known or suspected prostate cancer, hematocrit already high (treatment can worsen polycythemia), untreated severe sleep apnea, uncontrolled heart failure, and certain recent cardiovascular events — discuss with your clinician.
- Monitoring during therapy: symptoms and serum testosterone (adjust dose), hematocrit (at ~3–6 months then periodically; stop or lower therapy if hematocrit rises >50–54%), PSA (periodically per age/risk), and clinical assessment.
- Discuss possible side effects: increased hematocrit, acne, fluid retention, worsening sleep apnea, possible effects on cardiovascular risk (data mixed).
Practical next steps
- If you have symptoms: get an early-morning total testosterone test (LabCorp or Quest Diagnostics are commonly used labs). If the result is low, repeat the test and see your primary care doctor, urologist, or endocrinologist for further evaluation (major centers like Mayo Clinic or Cleveland Clinic have specialists if you want a tertiary referral).
- If you’d like, tell me your morning total testosterone value (with units) and your main symptoms and I can help interpret and suggest questions to bring to your clinician.
References/guidelines to look up
- Endocrine Society clinical practice guideline on testosterone therapy
- American Urological Association guideline on testosterone deficiency
If you want, I can walk through what to expect from the bloodwork order, explain free testosterone reporting, or help draft questions to ask your doctor.